MindBio Therapeutics Corp.
MBQIF
$0.36
-$0.12-25.00%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -1.41M | -1.59M | -790.30K | -922.50K | -590.80K |
| Total Depreciation and Amortization | -- | -- | -- | -56.80K | 0.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 969.40K | 1.12M | 764.20K | 467.40K | 620.30K |
| Change in Net Operating Assets | 14.10K | -37.60K | -1.50K | 375.70K | -70.70K |
| Cash from Operations | -426.60K | -501.80K | -27.60K | -136.20K | -41.30K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 6.40K | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 6.40K | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -1.30K | 0.00 |
| Issuance of Common Stock | 346.70K | 1.16M | -- | 275.40K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -400.00 | -- |
| Cash from Financing | 237.90K | 763.40K | -- | 175.40K | 0.00 |
| Foreign Exchange rate Adjustments | -53.40K | -- | -- | -13.60K | 3.10K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -242.10K | 261.60K | -27.60K | 31.90K | -38.20K |